Omeros | OMER - Trade Debtors


Omeros reported $8.08M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Adma Biologics USD 135.86M 22.57M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Cytokinetics USD 6.83M 10.94M Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Immunic USD 333K 156K Dec/2025
Insmed USD 215.32M 36.77M Jun/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
MacroGenics USD 10.42M 2.95M Mar/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 132.42M 6.78M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Rockwell Medical USD 10.84M 250K Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
United Therapeutics USD 310.3M 1.7M Jun/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026